Work

Plasma Tumor Mutation Burden and Response to Pembrolizumab—Response

Year: 2020

Type: letter

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-20-1073

Authors: Charu Aggarwal, Jeffrey C. Thompson, Erica L. Carpenter

Institution: University of Pennsylvania

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Abramson Cancer Center Support Grant

OpenAlex ID: W4247595475

Cites: 2

Cited by: 2

Related to: 10